Contenidos referenciales
Actualizaciones sobre AEH
Programa del estudio clínico HELP
Programa a largo plazo
para Angioedema Hereditário
Haga clic aquí para acceder al folleto de Takhzyro®
Abrir documento
Referencia:
- Riedl MA, Bernstein JA, Craig T, et al. An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema: design of the HELP study extension.Clinical and Translational Allergy 2017; 7: 36.